Cell Therapy for the degenerating intervertebral discs
退变椎间盘细胞疗法
基本信息
- 批准号:7687031
- 负责人:
- 金额:$ 4.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-01-20 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirusesAllogenicAnimalsAttentionBack PainBasic ScienceBiochemicalBiologicalBone Morphogenetic ProteinsCell CountCell SurvivalCell TherapyCellsChondrocytesClinicalCollagenCollagen Type IIControl GroupsDataDevelopmentDiagnostic radiologic examinationEconomicsEnvironmentEnzyme-Linked Immunosorbent AssayEtiologyExcisionExpression FeatureFluorescence MicroscopyGene TransferGenesGreen Fluorescent ProteinsGrowth FactorHeightHomeostasisImageIn VitroInjection of therapeutic agentInjuryInternationalIntervertebral disc structureLearningLettersMagnetic Resonance ImagingMaintenanceManuscriptsMedicalMentorsMethodsModelingNumbersOperative Surgical ProceduresOryctolagus cuniculusOutcome MeasurePhenotypePhysiciansPhysiologicalProductionProteinsProteoglycanProtonsPublishingPuncture procedureRehabilitation therapyResearchResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRoleScientistSeasonsSurgeonTechnical ExpertiseTechniquesTissuesTodayTrainingTraining ProgramsTransduction GeneTransplantationUnited StatesUniversitiesVertebral columnWeekWeightWorkabstractingaggrecanaging populationbasebone morphogenetic protein 7careercostdensitydesignexperiencegene therapyhuman osteogenic protein 1in vivoindexinginjuredinterestintervertebral disk degenerationprogramsrepairedresearch and developmenttool
项目摘要
DESCRIPTION (provided by applicant): The trainee is a young physician with a strong basic science background. With the guidance of the rehabilitation scientist training program (RMSTP), she has designed a career path that brings together her scientific and clinical interests. Her research has attracted a considerable amount of positive attention in the field of rehabilitation. Seven full manuscripts resulted from this work: three have been published, one in press (see attached manuscript and letter), and three are in review. In addition, 15 abstracts have been presented at national and international meetings. The proposed research development plan will allow her to gain additional technical expertise under the guidance of seasoned scientists, and become an independent clinician-investigator.
The trainee's research plan addresses an immensely important clinical problem, back pain. Although the etiology of back pain is most likely multi-factorial, intervertebral disc degeneration is perhaps causally associated with back pain. Biological treatment with a growth factor may promote matrix repair and restore physiological function. Cell-based gene therapy, which aims at the sustained release of growth factors, will be explored.
This revised proposal contains new data further supporting the central hypothesis that cell therapy is likely to represent an effective tool for slowing or even reversing disc degeneration (1) Rabbit intervertebral disc (IVD) explants injected with allogenic rabbit articular chondrocytes transduced with Ad-hBMP-7 produce more hBMP-7 protein, and (2) Rabbit IVD explants injected with articular chondrocytes expressing hBMP-7 accumulate more proteoglycans. Based on these findings, the trainee proposes to study the effects of BMP-7 on degenerative rabbit intervertebral discs using the ex vivo gene transfer method. She has also performed a pilot in vivo study and transplanted allogenic rabbit articular chondrocytes into the degeneration rabbit IVD, demonstrating her ability to perform in vivo studies.
Dr. Irving Shapiro, a disc biologist, has assumed the role of the trainee's primary mentor. Her in vivo study will also be helped by Dr. D. Greg Anderson, a spine surgeon, with extensive experience with the animal disc injury model. In the revised training plan, the trainee proposes to participate in course work and to learn additional techniques. Thomas Jefferson University provides a rich environment, and has a strong commitment to support her career development.
描述(由申请人提供): 受训者是一位具有深厚基础科学背景的年轻医生。在康复科学家培训计划(RMSTP)的指导下,她设计了一条将她的科学和临床兴趣结合起来的职业道路。她的研究在康复领域引起了相当多的积极关注。这项工作产生了七份完整的手稿:三份已出版,一份正在印刷(见所附手稿和信件),三份正在审查中。此外,15 篇摘要已在国内和国际会议上发表。拟议的研究发展计划将使她能够在经验丰富的科学家的指导下获得额外的技术专业知识,并成为一名独立的临床医生研究员。
实习生的研究计划解决了一个非常重要的临床问题:背痛。尽管背痛的病因很可能是多因素的,但椎间盘退变可能与背痛有因果关系。生长因子的生物治疗可以促进基质修复并恢复生理功能。将探索旨在持续释放生长因子的细胞基因疗法。
该修订后的提案包含进一步支持中心假设的新数据,即细胞疗法可能代表减缓甚至逆转椎间盘退变的有效工具(1)注射用Ad-hBMP-转导的同种异体兔关节软骨细胞的兔椎间盘(IVD)外植体7 产生更多的 hBMP-7 蛋白,并且 (2) 注射表达 hBMP-7 的关节软骨细胞的兔 IVD 外植体积累更多蛋白多糖。基于这些发现,学员提出利用离体基因转移方法研究BMP-7对退变兔椎间盘的影响。她还进行了一项试点体内研究,并将同种异体兔关节软骨细胞移植到变性兔 IVD 中,证明了她进行体内研究的能力。
椎间盘生物学家 Irving Shapiro 博士担任了学员的主要导师。她的体内研究也将得到脊柱外科医生 D. Greg Anderson 博士的帮助,他在动物椎间盘损伤模型方面拥有丰富的经验。在修订后的培训计划中,学员建议参加课程作业并学习额外的技术。托马斯杰斐逊大学提供了丰富的环境,并坚定地致力于支持她的职业发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YEJIA ZHANG其他文献
YEJIA ZHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YEJIA ZHANG', 18)}}的其他基金
Inhibition of TNF-alpha Signaling to Reduce Intervertebral Disc Inflammation
抑制 TNF-α 信号传导以减少椎间盘炎症
- 批准号:
10301274 - 财政年份:2021
- 资助金额:
$ 4.65万 - 项目类别:
Inhibition of TNF-alpha Signaling to Reduce Intervertebral Disc Inflammation
抑制 TNF-α 信号传导以减少椎间盘炎症
- 批准号:
10448429 - 财政年份:2021
- 资助金额:
$ 4.65万 - 项目类别:
Cell Therapy for the Degenerating Intervertebral Disc
退变椎间盘细胞疗法
- 批准号:
9032599 - 财政年份:2015
- 资助金额:
$ 4.65万 - 项目类别:
Cell Therapy for the degenerating intervertebral discs
退变椎间盘细胞疗法
- 批准号:
8010767 - 财政年份:2010
- 资助金额:
$ 4.65万 - 项目类别:
Cell Therapy for the degenerating intervertebral discs
退变椎间盘细胞疗法
- 批准号:
7752557 - 财政年份:2007
- 资助金额:
$ 4.65万 - 项目类别:
Cell Therapy for the degenerating intervertebral discs
退变椎间盘细胞疗法
- 批准号:
7342105 - 财政年份:2007
- 资助金额:
$ 4.65万 - 项目类别:
Cell Therapy for the degenerating intervertebral discs
退变椎间盘细胞疗法
- 批准号:
7212018 - 财政年份:2007
- 资助金额:
$ 4.65万 - 项目类别:
Cell Therapy for the degenerating intervertebral discs
退变椎间盘细胞疗法
- 批准号:
7544928 - 财政年份:2007
- 资助金额:
$ 4.65万 - 项目类别:
相似国自然基金
肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
- 批准号:82303776
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CD46和DSG2双受体在人B组腺病毒感染与致病中的协同作用和机制研究
- 批准号:32370155
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
禽腺病毒血清11型反向遗传平台的建立与毒株间致病性差异机制探究
- 批准号:32372997
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
- 批准号:82302607
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PD-1/PD-L1信号促CD21-B细胞BCR髓外二次编辑降低自身反应性在儿童腺病毒肺炎中的作用机制研究
- 批准号:82370015
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
HIV-specific ex-vivo expanded T cell therapy (HXTC) to Deplete the Latent Reservoir of Persistent HIV Infection
HIV 特异性体外扩增 T 细胞疗法 (HXTC) 可消除持续性 HIV 感染的潜在储库
- 批准号:
9889986 - 财政年份:2016
- 资助金额:
$ 4.65万 - 项目类别:
Cell Therapy for the Degenerating Intervertebral Disc
退变椎间盘细胞疗法
- 批准号:
9032599 - 财政年份:2015
- 资助金额:
$ 4.65万 - 项目类别:
A single antiviral to treat multiple opportunistic infections
单一抗病毒药物可治疗多种机会性感染
- 批准号:
10602319 - 财政年份:2014
- 资助金额:
$ 4.65万 - 项目类别:
CD19-Specific CB T-cell Therapy for Patients with B-cell Malignancies
针对 B 细胞恶性肿瘤患者的 CD19 特异性 CB T 细胞疗法
- 批准号:
8555383 - 财政年份:2011
- 资助金额:
$ 4.65万 - 项目类别:
Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT
抗病毒和抗白血病 T 细胞治疗作为 HSCT 后的预防
- 批准号:
8316198 - 财政年份:2011
- 资助金额:
$ 4.65万 - 项目类别: